|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
This article has been cited by other articles:
![]() |
M. Hlaing, P. Spitz, K. Padmanabhan, B. Cabezas, C. S. Barker, and H. S. Bernstein E2F-1 Regulates the Expression of a Subset of Target Genes during Skeletal Myoblast Hypertrophy J. Biol. Chem., October 15, 2004; 279(42): 43625 - 43633. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, H. Zhang, D. Wang, D. Ma, Y. Shen, and Y. Shang DLP, a Novel Dim1 Family Protein Implicated in Pre-mRNA Splicing and Cell Cycle Progression J. Biol. Chem., July 30, 2004; 279(31): 32839 - 32847. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ajuh and A. I. Lamond Identification of peptide inhibitors of pre-mRNA splicing derived from the essential interaction domains of CDC5L and PLRG1 Nucleic Acids Res., November 1, 2003; 31(21): 6104 - 6116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hlaing, X. Shen, P. Dazin, and H. S. Bernstein The Hypertrophic Response in C2C12 Myoblasts Recruits the G1 Cell Cycle Machinery J. Biol. Chem., June 21, 2002; 277(26): 23794 - 23799. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Engemann, V. Heinzel, G. Page, U. Preuss, and K. H. Scheidtmann DAP-like kinase interacts with the rat homolog of Schizosaccharomyces pombe CDC5 protein, a factor involved in pre-mRNA splicing and required for G2/M phase transition Nucleic Acids Res., March 15, 2002; 30(6): 1408 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ajuh, J. Sleeman, J. Chusainow, and A. I. Lamond A Direct Interaction between the Carboxyl-terminal Region of CDC5L and the WD40 Domain of PLRG1 Is Essential for Pre-mRNA Splicing J. Biol. Chem., November 2, 2001; 276(45): 42370 - 42381. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Berge, S. L. Bergholtz, K. B. Andersson, and O. S. Gabrielsen A novel yeast system for in vivo selection of recognition sequences: defining an optimal c-Myb-responsive element Nucleic Acids Res., October 15, 2001; 29(20): e99 - e99. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||